NTBLQ — Notable Labs Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$3.79m
- $0.31m
Vascular Biogenics Ltd expected to post a loss of 11 cents a share - Earnings Preview
Chardan sees multiple catalysts for VBL Therapeutics in 2022
U.S. STOCKS ON THE MOVE-Tesla Inc, Microsoft Corp, MSCI Inc
U.S. STOCKS ON THE MOVE-Opthea Ltd, Carnival Corp, Tesla Inc
U.S. STOCKS ON THE MOVE-Polaris Inc, Invesco Ltd, Corning Inc
VBL Therapeutics jumps on 'fast track' tag for cancer therapy
Brief: VBL Therapeutics Receives FDA Fast Track Designation for Ofra-Vec
Vascular Biogenics Ltd reports results for the quarter ended in December - Earnings Summary
Brief: VBL Therapeutics Reports Full Year 2021 Financial Results
Vascular Biogenics Ltd expected to post a loss of 9cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Amazon, JD.com, CrowdStrike
Brief: VBL Therapeutics Announces Completion Of Enrollment In Oval Phase 3 Trial Of Ofra-Vec
Brief: Vbl Therapeutics Announces Appointment Of Matthew Trudeau As Chief Commercial Officer
Brief: VBL Therapeutics Selected For EUR 17.5 Mln Of Funding From Horizon Europe EIC Accelerator Program
Vascular Biogenics Ltd reports results for the quarter ended in September - Earnings Summary
Brief: VBL Therapeutics Reports Third Quarter 2021 Financial Results
Vascular Biogenics Ltd expected to post a loss of 11 cents a share - Earnings Preview
Brief: VBL Therapeutics Announces Appointment Of Sam Backenroth As CFO And Establishes Operations In The United States
U.S. STOCKS ON THE MOVE-Protagonist Therapeutics, ForgeRock, Beigene